BD expands U.S. manufacturing capacity for syringes, needles and IV catheters

BD announced additional investments in its U.S. manufacturing network, including new needle and syringe production lines in Connecticut and Nebraska, and plans for over $30 million in 2025 to expand IV line capacity in Utah. The company hired more than 215 employees.

“Domestic manufacturing is crucial for ensuring a resilient supply of essential health care devices.”investors.bd.com

• 1 source
• investors.bd.comBD Boosts U.S. Manufacturing of Critical Medical Devices :: Becton, Dickinson and Company (BDX)Jan 15, 2025

Summarized from public sources; check the original articles before acting on it.